ExodusPoint Capital Management LP Invests $1.10 Million in Integra LifeSciences Holdings Co. (NASDAQ:IART)

ExodusPoint Capital Management LP bought a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 48,332 shares of the life sciences company's stock, valued at approximately $1,096,000. ExodusPoint Capital Management LP owned 0.06% of Integra LifeSciences as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC lifted its holdings in shares of Integra LifeSciences by 599.6% during the 4th quarter. Nisa Investment Advisors LLC now owns 3,267 shares of the life sciences company's stock worth $74,000 after acquiring an additional 2,800 shares during the period. Empowered Funds LLC acquired a new position in Integra LifeSciences during the 4th quarter worth about $180,000. Centiva Capital LP acquired a new stake in shares of Integra LifeSciences in the third quarter valued at approximately $192,000. Mitsubishi UFJ Asset Management UK Ltd. acquired a new position in shares of Integra LifeSciences during the fourth quarter valued at $204,000. Finally, Romano Brothers AND Company bought a new position in shares of Integra LifeSciences in the 4th quarter valued at about $204,000. 84.78% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Argus upgraded Integra LifeSciences from a "hold" rating to a "buy" rating in a research report on Monday, March 31st. Truist Financial cut their price target on shares of Integra LifeSciences from $26.00 to $19.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $22.71.

Integra LifeSciences Stock Performance

Shares of NASDAQ IART traded up $0.09 during mid-day trading on Wednesday, reaching $16.17. 69,303 shares of the company were exchanged, compared to its average volume of 1,047,376. The company's 50-day simple moving average is $21.88 and its 200-day simple moving average is $22.29. The company has a quick ratio of 0.73, a current ratio of 1.20 and a debt-to-equity ratio of 0.79. The stock has a market capitalization of $1.25 billion, a P/E ratio of -179.59, a P/E/G ratio of 0.73 and a beta of 1.24. Integra LifeSciences Holdings Co. has a twelve month low of $15.87 and a twelve month high of $32.66.

Integra LifeSciences (NASDAQ:IART - Get Free Report) last posted its earnings results on Tuesday, February 25th. The life sciences company reported $0.97 earnings per share for the quarter, topping analysts' consensus estimates of $0.85 by $0.12. Integra LifeSciences had a positive return on equity of 12.35% and a negative net margin of 0.42%. The company had revenue of $442.65 million during the quarter, compared to the consensus estimate of $445.15 million. During the same quarter last year, the firm earned $0.89 earnings per share. The company's revenue was up 11.5% on a year-over-year basis. As a group, research analysts predict that Integra LifeSciences Holdings Co. will post 2.45 earnings per share for the current year.

Integra LifeSciences Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.